Mostrar el registro sencillo del ítem

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials.

dc.contributor.authorGómez-Reino Carnota, Juan Jesús 
dc.date.accessioned2017-06-07T07:34:00Z
dc.date.available2017-06-07T07:34:00Z
dc.date.issued2014
dc.identifier.issn2326-5191
dc.identifier.urihttp://hdl.handle.net/20.500.11940/8036
dc.language.isoeng
dc.titleApremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials.
dc.typePublicación de congreso
dc.authorsophosKavanaugh, A
dc.authorsophosCutolo, M
dc.authorsophosMease, P
dc.authorsophosGladman, DD
dc.authorsophosAdebajo, AO
dc.authorsophosGomez-Reino, J
dc.authorsophosWollenhaupt, J
dc.authorsophosSchett, GA
dc.authorsophosLespessailles, E
dc.authorsophosHu, CH
dc.authorsophosStevens, RM
dc.authorsophosEdwards, C
dc.authorsophosBirbara, CA
dc.identifier.isi344384901092
dc.identifier.sophos16289
dc.issue.numberSupl 1
dc.journal.titleArthritis and Rheumatology
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Reumatoloxía
dc.page.initialS239
dc.page.finalS240
dc.rights.accessRightsopenAccess
dc.typesophosComunicaciones a congresos
dc.volume.number66


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem